The analysis and clinical application cellular characteristics of lung carcinoma or thyroid cancer using radionuclide tracer
The analysis and clinical application cellular characteristics of lung carcinoma or thyroid cancer using radionuclide tracer
批准号:
12670914
负责人:
ISHIBASHI Masatoshi
金额:
$1.54万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2002
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Although thallium-201 (^<201>Tl) uptake is related to perfusion in many normal tissues, the biologic rationale for ^<201>Tl uptake in tumors is uncertain. To determine if tumor uptake is related to cell proliferation, we correlated the relative retention of ^<201>Tl in lung tumors with expression of Ki-67, an indicator of cell proliferation. Methods : Sixty patients with lung tumors, included small cell carcinoma (n=8) and non-small cell carcinoma (n=52), underwent ^<201>Tl single photon emission computed tomography (SPECT) imaging. The ^<201>Tl lesion uptake was determined on early and delayed images and the radiotracer retention index (RI) was calculated. Tumor specimens were obtained at surgery or bronchoscopy. The cell proliferation ratio was estimated using MIB-1, a monoclonal antibody that recognized the nuclear antigen Ki-67.The average ^<201>Tl index was 2.13 + 0.61 (early) and 2.46 ± 0.83 (delayed). The average RI was 17.44 ± 35.01. Overall, the ^<201>Tl index (delayed) and the cancer cell proliferation were correlated (r=0.70, p<.0001). Of interest, there was a significant correlation (r=.872, p<.0005) between the ^<201>Tl index on delayed images and cell proliferation ratio in patients with small cell but not non-small cell lung carcinoma. The ^<201>Tl index (delayed) was significantly higher (p<.0001) for patients with small cell lung carcinoma than for patients with non-small cell lung carcinoma. In conclusion, ^<201>Tl imaging appears to be useful for evaluating patients with small cell lung carcinoma but not non-small lung carcinoma, and is correlated with the monoclonal antibody MIB-1, a marker for cell proliferation.Next step, we have evaluated the cell proliferation and rate of proliferation for patients with non-small lung carcinoma or thyroid cancer using the specific antibody recognized to MAPK/ERK. The resultant data obtained by us can be presented within a couple of months.
期刊论文(11)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Masatoshi Ishibashi: "Relationship between cancer cell proliferation and thallium-201 uptake in lung Cancer"Annals of Nuclear Medicine. 14・4. 255-261 (2000)
Masatoshi Ishibashi:“肺癌中癌细胞增殖和铊201摄取之间的关系”核医学年鉴14・4(2000)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ishibasi M: "Relationship between cancer cell proliferation and thallium-201 uptake in Lung Cancer"Ann Nucl Med. 14. 255-261 (2000)
Ishibasi M:“肺癌中癌细胞增殖与铊 201 摄取之间的关系”Ann Nucl Med。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Fujii T: "Cliricopathologic study of noevasucularization and VEGF expression in 8uperficial esophageal carunoma"Int. J. Oncol. 21. 1181-1187 (2002)
Fujii T:“8例食管浅部癌中血管生成和VEGF表达的临床病理学研究”Int。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Fujii T: "Involvement of PKC8 in phorbol ester-induced apoptosis in LNCaP prostate cancer cells. Lack of proteolytic cleavage of PKC8"J Biol Chem. 275. 7574-7582 (2000)
Fujii T:“PKC8 参与佛波酯诱导的 LNCaP 前列腺癌细胞凋亡。PKC8 缺乏蛋白水解裂解”J Biol Chem。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ishibashi M, et al.: "Relationship between Cancer Cell Proliferation and Thallium-201 Uptake in Lung Cancer"Ann Nucl Med. 14. 255-261 (2000)
Ishibashi M 等人:“肺癌中癌细胞增殖与铊 201 摄取之间的关系”Ann Nucl Med。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 9 条
The investigation of both FDG uptake mechanism and predicton prognosis using PET/CT in pancreatic cancer patients
-
批准号:23591807
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.16万
-
财政年份:2011
-
负责人:ISHIBASHI Masatoshi
-
依托单位:
Molecular pathological evaluation of therapeutic effect using PET/CT in patients with esophageal cancer
-
批准号:20591465
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.08万
-
财政年份:2008
-
负责人:ISHIBASHI Masatoshi
-
依托单位:
Cellular characteristics and clinical assessment of breast cancer using F-18 FDG-PET
-
批准号:17591304
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.35万
-
财政年份:2005
-
负责人:ISHIBASHI Masatoshi
-
依托单位:
海外基金